T1D
Clinical trials for T1D explained in plain language.
Never miss a new study
Get alerted when new T1D trials appear
Sign up with your email to follow new studies for T1D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new drug called CNP-103 in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive multiple doses of CNP-103 or a placebo o…
Matched conditions: T1D
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated May 17, 2026 06:23 UTC
-
Pig cell transplant could free diabetics from severe low blood sugar
Disease control Recruiting nowThis early-phase study tests a new treatment called OPF-310, which uses pig islet cells enclosed in a protective capsule, for people with unstable type 1 diabetes who still experience dangerous low blood sugar episodes despite using an automated insulin pump and continuous glucos…
Matched conditions: T1D
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Scientists track insulin production for years in diabetes study
Knowledge-focused Recruiting nowThis study is observing people who previously participated in type 1 diabetes treatment trials. Researchers will follow them for up to five years to see how long their bodies continue to produce insulin naturally and how their immune systems change over time. The goal is to gathe…
Matched conditions: T1D
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC